Study Evaluating the Safety, Pharmacokinetics (PK), and Pharmacodynamices (PD) of HSD-016

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Subjects

In brief

This is intended to provide an initial safety assessment of HSD-016 and also to evaluate how the drug is absorbed and eliminated and its effect on the body in healthy subjects.

Key facts

Study ID

NCT00838461

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

32

Starts

2009-03-01

Expected to finish

2009-06-01

Last updated by the study team

2009-08-03

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men or women of nonchildbearing potential aged 18 to 50 years.
• Healthy as determined by investigator on the basis of medical history and physical examination, laboratory test results, and 12-lead ECG. 3. Nonsmoker or smoker of fewer than 10 cigarettes per day.

You may not qualify if…

• No history of thyroid abnormalities.
• No presence or history of any disorder that may prevent the successful completion of the study.
• No history of drug abuse.
• No use of any systemic steroids for 3 months.
• No history of claustrophobia.

Where it is running

• Study site — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.